Scientific & Medical

The AATB Grant Program, advanced by the AATB Foundation, is now accepting Letters of Intent (LOIs) for innovative, hypothesis-driven research that advances scientific understanding, strengthens industry practices, and unlocks new possibilities for allograft tissues.

We are excited to announce the two research projects selected as recipients of this year’s AATB G

AATB is aware of the FDA Safety Communication issued on July 10, 2026, titled Important Information for Human Cell, Tissue, and Cellular and Tissue-based Product (HCT/P) Establishments Regarding Ebola Disease and HCT/P Donation. 

We are pleased to announce the publication of a new editorial, “Uses of Human Tissue Bioburden Data,” authored by AATB’s Dr. Melissa Greenwald and Eduardo Nunes, highlighting the importance of human tissue bioburden information in supporting tissue safety and quality practices. 

We are pleased to announce the publication of novel research advancing the evaluation of meniscus allografts and supporting improved outcomes in transplantation and tissue banking.

AATB is pleased to announce the release of an updated version of the Sepsis Pilot Study Report, originally published in September 2024.

AATB is now accepting Letters of Intent (LOIs) for its Grant Program, supporting research that advances the field of tissue banking.

We are excited to announce that, following a rigorous review and evaluation by the STAC Grant Subcommittee, two proposals have been selected as this year’s AATB Grant Program recipients.

AATB is pleased to announce the publication of "Real-World Data to Improve Organ and Tissue D